The biology of VEGF and its receptors, Nature Medicine, vol.99, issue.21, pp.669-676, 2003. ,
DOI : 10.1073/pnas.152324099
Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor 2(flk-1) Are Expressed during Vasculogenesis and Vascular Differentiation in the Quail Embryo, Developmental Biology, vol.169, issue.2, pp.699-712, 1995. ,
DOI : 10.1006/dbio.1995.1180
Case history: Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer, Nature Reviews Drug Discovery, vol.81, issue.5, pp.391-400, 2004. ,
DOI : 10.1016/S1359-6349(03)91004-4
Inflammatory Allergy Drug Targets, British Journal of Ophthalmology, vol.10, issue.2012, pp.497-508, 2011. ,
S81-85 ; b) Holash, Clinical Colorectal Cancer J, vol.4, issue.2, 2004. ,
Approved in the EU for Patients with Previously Treated Metastatic Colorectal Cancer http ,
An overview of small-molecule inhibitors of VEGFR signaling, Nature Reviews Clinical Oncology, vol.15, issue.10, pp.569-579, 2009. ,
DOI : 10.1016/S0002-9440(10)65021-3
Tyrosine Kinase Inhibitors of Vascular Endothelial Growth Factor Receptors in Clinical Trials: Current Status and Future Directions, The Oncologist, vol.11, issue.7, pp.753-764, 2006. ,
DOI : 10.1634/theoncologist.11-7-753
Sunitinib in solid tumors, Expert Opinion on Investigational Drugs, vol.26, issue.6, pp.821-834, 2009. ,
DOI : 10.1016/j.jsbmb.2007.09.004
FDA approves Sutent for rare type of pancreatic cancer ,
Molecular Cancer Therapeutics, Acta Pharmacologica Sinica, vol.7, issue.201210, pp.3129-3140, 2008. ,
FDA Approves Nexavar for Patients with Inoperable Liver Cancer, 2007. ,
The Journal of Chemical Physics, pp.5648-5652, 1993. ,
The influence of polarization functions on molecular orbital hydrogenation energies, Theoretica Chimica Acta, vol.53, issue.3, pp.213-222, 1973. ,
DOI : 10.1007/BF00533485
Design, synthesis, biological evaluation and X-ray crystal structure of novel classical 6,5,6-tricyclic benzo[4,5]thieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors, Bioorganic & Medicinal Chemistry, vol.19, issue.11, pp.3585-3594, 2011. ,
DOI : 10.1016/j.bmc.2011.03.067
]pyrimidin-4-one Scaffold via Regioselective Alkylation Reactions, Journal of Combinatorial Chemistry, vol.11, issue.3, pp.508-514, 2009. ,
DOI : 10.1021/cc9000373
Synthesis and antiviral/antitumor evaluation of 2-amino- and 2-carboxamido-3-arylsulfonylthiophenes and related compounds as a new class of diarylsulfones, Bioorganic & Medicinal Chemistry, vol.9, issue.5, pp.1123-1132, 2001. ,
DOI : 10.1016/S0968-0896(00)00333-3
Selective Preparation of 4-(Bromo or Iodo)-2,5-dimethoxybenzonitrile and 2-(Bromo or Iodo)-3,6-dimethoxybenzonitrile from 2,5-Dimethoxybenzaldehyde, Synthetic Communications, vol.6, issue.24, pp.4629-4637, 1998. ,
DOI : 10.1016/S0040-4039(01)80650-X
Synthèse séquentielle des dérivés urées RMN 1 H (400MHz, DMSO-d 6 ) : ? = 4.99 (s, 2H, pp.93-100 ,
Synthèse séquentielle des dérivés urées RMN 1 H (400MHz, DMSO-d 6 ) : ? = 4.02 (s, 2H, p.97 ,
72 (s, NH urée) (s, NH urée), pp.37-44 ,
Synthèse séquentielle des dérivés urées f. 1-(4-Chloro-3-(trifluorométhyl)phényl)-3-(4-(((4-oxo-3,4- dihydrothiéno[2,3-d]pyrimidin-2-yl)méthyl)thio)phényl)urée 71 ,
Synthèse séquentielle des dérivés urées 1. 1 a), Synlett, issue.06, pp.855-0857, 2003. ,
Preparation of thieno[2,3-b]pyrroles starting from ketene-N,S-acetals, Tetrahedron, vol.59, issue.9, pp.1557-1564, 2001. ,
DOI : 10.1016/S0040-4020(03)00054-1
Microwave-assisted synthesis of 2-aminothiophene-3-carboxylic acid derivatives, 3H-thieno[2,3-d]pyrimidin-4-one and 4-chlorothieno[2,3-d]pyrimidine, Tetrahedron Letters, vol.48, issue.30, pp.5261-5264, 2007. ,
DOI : 10.1016/j.tetlet.2007.05.136
]pyrimidines, Journal of Heterocyclic Chemistry, vol.128, issue.3, pp.459-464, 2009. ,
DOI : 10.1002/jhet.107
Targeting cancer with small molecule kinase inhibitors, Nature Reviews Cancer, vol.62, issue.1, pp.28-39, 2009. ,
DOI : 10.1016/S0092-8674(03)00194-6
Mini-Reviews in Medicinal Chemistry, pp.920-946, 2011. ,
Annals of Surgery, pp.409-416, 1972. ,
Design, synthesis and biological evaluation of new classes of thieno[3,2-d]pyrimidinone and thieno[1,2,3]triazine as inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2), European Journal of Medicinal Chemistry, vol.63, pp.765-781, 2013. ,
DOI : 10.1016/j.ejmech.2013.03.022
URL : https://hal.archives-ouvertes.fr/hal-00826273
Vascular endothelial growth factor is a secreted angiogenic mitogen, Science, vol.246, issue.4935, pp.1306-1309, 1989. ,
DOI : 10.1126/science.2479986
Angiogenesis in life, disease and medicine, Nature, vol.Teill II, issue.7070, pp.932-936, 2005. ,
DOI : 10.1053/j.seminoncol.2004.03.034
Vasculogenesis and angiogenesis in the endometrium during menstrual cycle and implantation, Acta Histochemica, vol.112, issue.3, pp.203-214, 2010. ,
DOI : 10.1016/j.acthis.2009.04.004
Regulators of Angiogenesis, Annual Review of Physiology, vol.53, issue.1, pp.217-239, 1991. ,
DOI : 10.1146/annurev.ph.53.030191.001245
Etude, synthèse et évaluation de composés en série hétérocyclique à activité inhibitrice ,
Vasculogenesis, Annual Review of Cell and Developmental Biology, vol.11, issue.1, pp.73-91, 1995. ,
DOI : 10.1146/annurev.cb.11.110195.000445
The Role of Angiopoietin-Like Proteins in Angiogenesis and Metabolism, Trends in Cardiovascular Medicine, vol.18, issue.1, pp.6-14, 2008. ,
DOI : 10.1016/j.tcm.2007.10.003
PDGF, TGF-??, and Heterotypic Cell???Cell Interactions Mediate Endothelial Cell???induced Recruitment of 10T1/2 Cells and Their Differentiation to a Smooth Muscle Fate, The Journal of Cell Biology, vol.144, issue.3, pp.805-814, 1998. ,
DOI : 10.1074/jbc.271.25.15008
Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb., Journal of Clinical Investigation, vol.101, issue.1, pp.40-50, 1998. ,
DOI : 10.1172/JCI119877
The biology of VEGF and its receptors, Nature Medicine, vol.99, issue.21, pp.669-676, 2003. ,
DOI : 10.1073/pnas.152324099
Vascular endothelial growth factor receptors: Molecular mechanisms of activation and therapeutic potentials, Experimental Eye Research, vol.83, issue.5, pp.1005-1016, 2006. ,
DOI : 10.1016/j.exer.2006.03.019
Thérapie anti-angiogénique et risque thrombotique, problème d'actualité, Thèse de Doctorat de l'Université Henri Poincaré Nancy 1, 2008. ,
Angiogenesis: Tumorigenesis and the angiogenic switch, Nature Reviews Cancer, vol.3, issue.6, pp.401-410, 2003. ,
DOI : 10.1038/nrc1093
Hypoxia Regulates Vascular Endothelial Growth Factor Gene Expression in Endothelial Cells : Identification of a 5' Enhancer, Circulation Research, vol.77, issue.3, pp.638-643, 1995. ,
DOI : 10.1161/01.RES.77.3.638
L'hypoxie tumorale peut-elle devenir un avantage pour la chimiothérapie ?, p.7, 2008. ,
eNOS Activation by Physical Forces: From Short-Term Regulation of Contraction to Chronic Remodeling of Cardiovascular Tissues, Physiological Reviews, vol.89, issue.2, pp.481-534, 2009. ,
DOI : 10.1067/mob.2000.104205
Blood vessels and nerves: common signals, pathways and diseases, Nature Reviews Genetics, vol.107, issue.9, pp.710-720, 2003. ,
DOI : 10.1046/j.1469-7580.2000.19740591.x
VEGF and endothelial guidance in angiogenic sprouting, Organogenesis, vol.444, issue.4, pp.241-246, 2008. ,
DOI : 10.1007/978-0-387-78632-2_3
VEGF as a Key Mediator of Angiogenesis in Cancer, Oncology, vol.45, issue.3, pp.4-10, 2005. ,
DOI : 10.1038/nm988
The Biology of Vascular Endothelial Growth Factor, Endocrine Reviews, vol.18, issue.1, pp.4-25, 1997. ,
DOI : 10.1210/edrv.18.1.0287
Cold Spring Harbor Perspectives in, Medicine, vol.2012, issue.27, pp.6-502 ,
Recruitment and Activation of Phospholipase C??1 by Vascular Endothelial Growth Factor Receptor-2 Are Required for Tubulogenesis and Differentiation of Endothelial Cells, Journal of Biological Chemistry, vol.114, issue.18, pp.16347-16355, 2003. ,
DOI : 10.1128/MCB.19.7.4961
The Carboxyl Terminus of VEGFR-2 Is Required for PKC-mediated Down-Regulation, Molecular Biology of the Cell, vol.16, issue.4, pp.2106-2118, 2005. ,
DOI : 10.1091/mbc.E04-08-0749
Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibition, Cellular Signalling, vol.19, issue.10, pp.2003-2012, 2007. ,
DOI : 10.1016/j.cellsig.2007.05.013
Biochemical and Biophysical Research Communications, pp.287-291, 2008. ,
Conception, synthèse et évaluation pharmacologique de nouveaux dérivés quinazoliniques à visée anticancéreuse potentielle, Thèse de Doctorat Université de Lille 2, 2009. ,
Structure of a VEGF???VEGF receptor complex determined by electron microscopy, Nature Structural & Molecular Biology, vol.14, issue.3, pp.249-250, 2007. ,
DOI : 10.1074/jbc.M100763200
A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells, The EMBO Journal, vol.20, issue.11, pp.2768-2778, 2001. ,
DOI : 10.1093/emboj/20.11.2768
Substitution of C-terminus of VEGFR-2 with VEGFR-1 promotes VEGFR-1 activation and endothelial cell proliferation, Oncogene, vol.23, issue.32, pp.5523-5531, 2004. ,
DOI : 10.1074/jbc.M209712200
Combination of antiangiogenesis with chemotherapy for more effective cancer treatment, Molecular Cancer Therapeutics, vol.7, issue.12, pp.3670-3684, 2008. ,
DOI : 10.1158/1535-7163.MCT-08-0715
Les antiangiog??niques en oncologie digestive, Gastroent??rologie Clinique et Biologique, vol.32, issue.5, pp.504-520, 2008. ,
DOI : 10.1016/j.gcb.2008.01.042
Molecular mechanisms of action of antisense drugs, Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, vol.1489, issue.1, pp.31-44, 1999. ,
DOI : 10.1016/S0167-4781(99)00148-7
Anticorps humanisés en thérapeutique Direction générale des relations culturelles scientifiques et techniques. Médecine sciences M/S. http://EY9TU4HR4B.search.serialssolutions.com/?V=1.0&L=EY9TU4HR4B&S=JCs&C=M SM23SC&T=marc, 2005. ,
Case history: Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer, Nature Reviews Drug Discovery, vol.81, issue.5, pp.391-400, 2004. ,
DOI : 10.1016/S1359-6349(03)91004-4
Inflammatory Allergy Drug Targets, British Journal of Ophthalmology, vol.10, issue.2012, pp.497-508, 2011. ,
S81-85 ; b) Holash, Clinical Colorectal Cancer J.; Davis, S.; Papadopoulos, N.; Croll, S. D, issue.2, 2004. ,
Approved in the EU for Patients with Previously Treated Metastatic Colorectal Cancer http://en.sanofi.com/Images/31840_20130205_ZALTRAP_en.pdf, Nature Reviews Clinical Oncology Oncologist Angiogenesis, vol.86, issue.131, pp.569-579, 2006. ,
Sunitinib in solid tumors, Expert Opinion on Investigational Drugs, vol.26, issue.6, pp.821-834, 2009. ,
DOI : 10.1016/j.jsbmb.2007.09.004
FDA Approves Nexavar for Patients with Inoperable Liver Cancer, 2007. ,
Mini-Reviews in Medicinal Chemistry, pp.18-31, 2011. ,
Synthesis and biological activity of N4-phenylsubstituted-6-(2,4-dichloro phenylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic and antitumor agents, Bioorganic & Medicinal Chemistry, vol.18, issue.10, pp.3575-3587, 2010. ,
DOI : 10.1016/j.bmc.2010.03.052
2-Amino-4-methyl-5-phenylethyl substituted-7-N-benzyl-pyrrolo[2,3-d]pyrimidines as novel antitumor antimitotic agents that also reverse tumor resistance, Bioorganic & Medicinal Chemistry, vol.19, issue.14, pp.4355-4365, 2011. ,
DOI : 10.1016/j.bmc.2011.05.030
A novel pyrrolo[3, 2-d]pyrimidine derivative, as a vascular endothelial growth factor receptor and platelet-derived growth factor receptor tyrosine kinase inhibitor, shows potent antitumor activity by suppression of tumor angiogenesis, Cancer Science, vol.9, issue.5, pp.939-944, 2012. ,
DOI : 10.1126/science.1104819
QSAR and 3-D QSAR: principles and applications, Tetrahedron, vol.105, issue.643920, pp.9309-9314, 2008. ,
Synthesis and antiproliferative activity of 3-substituted 1H-indole [3,2-d]-1,2,3-triazin-4 (3H)-ones, European Journal of Medicinal Chemistry, vol.33, issue.1, pp.43-46, 1998. ,
DOI : 10.1016/S0223-5234(99)80074-9
Organic Letters, The Journal of Organic Chemistry, vol.115, issue.1414, pp.537-540, 1999. ,
Synthesis and SAR studies of novel antifungal 1,2,3-triazines, Bioorganic & Medicinal Chemistry Letters, vol.17, issue.18, pp.5222-5226, 2007. ,
DOI : 10.1016/j.bmcl.2007.06.076
Synthèse de thiophènes, sélénophènes, pyrroles et de leurs systèmes condensés à partir de cétènes, Thèse de Doctorat. UPVM, 2007. ,
Synthèse d'amino-thiophènes, sélénophènes, thiazoles, application à la synthèse d'analogues hétérocycliques de la Tacrine, Thèse de Doctorat. UPVM, 2008. ,
Synthèses d'analogues thiophéniques des paullones, agents antitumoraux potentiels, Thèse de Doctorat. UPVM, 2002. ,
The tautomerism of hydroxy derivatives of five-membered oxygen, nitrogen, and sulfur heterocycles, Tetrahedron Letters, vol.27, issue.28, pp.3275-3278, 1986. ,
DOI : 10.1016/S0040-4039(00)84773-5
Effects of substituents on the chlorination of methyl 3-hydroxythiophene-2-carboxylate and on the reaction of the resulting chlorinated products with active hydrogen containing compounds, Journal of Heterocyclic Chemistry, vol.89, issue.2, pp.315-319, 1990. ,
DOI : 10.1002/jhet.5570270237
Regioselective C-alkylation of alkyl 4-hydroxy-2-methylthiophene-3-carboxylates with ??-halo ketones, Russian Chemical Bulletin, vol.53, issue.3, pp.631-634, 2004. ,
DOI : 10.1023/B:RUCB.0000035648.41262.77
Characterization of LY806303 as a potent and selective inhibitor of thrombin, Bioorganic & Medicinal Chemistry Letters, vol.2, issue.9, pp.1025-1028, 1992. ,
DOI : 10.1016/S0960-894X(00)80611-3
WO2010037068(A2) 2010. 141. a) Moursounidis, J Tetrahedron Letters, issue.26, pp.27-3045, 1986. ,
A,B-Diheteropentalenes by a Tandem Intramolecular Diels-Alder/Reverse Diels-Alder Reaction Sequence. Application to the Synthesis of Thieno[3,4-b]furan, Targets in Heterocyclic Systems, pp.593-607, 1995. ,
DOI : 10.1071/CH9950593
Chemistry of Heterocyclic Compounds, pp.661-664, 1994. ,
]thiazoles, Journal of Heterocyclic Chemistry, vol.62, issue.1, pp.71-75, 1998. ,
DOI : 10.1002/jhet.5570350114
Bulletin of the Catalysis Society of India, Journal of the Chemical Society, Chemical Communications Synthetic Communications, vol.147, issue.3221, pp.1114-1115, 1988. ,
The Journal of Organic Chemistry, pp.9975-9982, 2011. ,
The Journal of Chemical Physics, pp.5648-5652, 1993. ,
The influence of polarization functions on molecular orbital hydrogenation energies, Theoretica Chimica Acta, vol.53, issue.3, pp.213-222, 1973. ,
DOI : 10.1007/BF00533485
Synthesis and photoluminescent properties of novel furopyrimidine derivatives, Synthetic Metals, vol.155, issue.3, pp.461-463, 2005. ,
DOI : 10.1016/j.synthmet.2005.06.017
Synthesis and anti-tumor activities of N???-benzylidene-2-(4-oxothieno[2,3-d]pyrimidin-3(4H)-yl)acetohydrazone derivatives, Bioorganic & Medicinal Chemistry Letters, vol.21, issue.22, pp.6662-6666, 2011. ,
DOI : 10.1016/j.bmcl.2011.09.061
AN ANTIMALARIAL ALKALOID FROM HYDRANGEA. XVIII. DERIVATIVES OF 4-PYRIMIDONE, The Journal of Organic Chemistry, vol.18, issue.2, pp.133-137, 1953. ,
DOI : 10.1021/jo01130a003
Monatshefte für Chemie -Chemical Monthly, pp.317-323, 2012. ,
Synthesis and antiviral/antitumor evaluation of 2-amino- and 2-carboxamido-3-arylsulfonylthiophenes and related compounds as a new class of diarylsulfones, Bioorganic & Medicinal Chemistry, vol.9, issue.5, pp.1123-1132, 2001. ,
DOI : 10.1016/S0968-0896(00)00333-3
Selective Preparation of 4-(Bromo or Iodo)-2,5-dimethoxybenzonitrile and 2-(Bromo or Iodo)-3,6-dimethoxybenzonitrile from 2,5-Dimethoxybenzaldehyde, Synthetic Communications, vol.6, issue.24, pp.4629-4637, 1998. ,
DOI : 10.1016/S0040-4039(01)80650-X
A New Synthesis of 2-Aryl-2H-Pyrazino[2,1-B]quinazolin-3,6[1H,4H)-diones, Synthetic Communications, vol.63, issue.2, pp.173-181, 1991. ,
DOI : 10.1039/p19740002122
Indian journal of chemistry, pp.1778-1781, 2006. ,
Diazachinodimethane, donorsubstituierte Pyrazine und Dihydropyrazine, Angewandte Chemie, vol.22, issue.9, pp.727-729, 1983. ,
DOI : 10.1002/ange.19670790308
Solubility in the Systems MCl (M = Na, K)???1,4-Dioxane???Water at 25 ^C, Journal of Solution Chemistry, vol.35, issue.9, pp.1329-1334, 2006. ,
DOI : 10.1007/s10953-006-9061-x
WO2011034907 (A2) 2011, b) Garcia Ruano, pp.315-317, 2007. ,
Design, Synthesis, Photophysics, and Ion-binding Studies of a Ditopic Receptor Based on Gold(I) Phosphine Thiolate Complex Functionalized with Crown Ether and Urea Binding Units, Inorganic Chemistry, vol.49, issue.5, pp.2273-2279, 2010. ,
DOI : 10.1021/ic9021068
Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of Cyclin D1-CDK4: Synthesis, biological evaluation, and structure???activity relationships, Bioorganic & Medicinal Chemistry Letters, vol.19, issue.2, pp.305-308, 2009. ,
DOI : 10.1016/j.bmcl.2008.11.090
Selective reduction of aromatic nitro compounds with stannous chloride in non acidic and non aqueous medium, Tetrahedron Letters, vol.25, issue.8, pp.839-842, 1984. ,
DOI : 10.1016/S0040-4039(01)80041-1
Advanced Synthesis & Catalysis, pp.217-219, 2005. ,
Tryptanthrin Inhibits Angiogenesis by Targeting the VEGFR2-Mediated ERK1/2 Signalling Pathway, PLoS ONE, vol.303, issue.12, p.82294, 2013. ,
DOI : 10.1371/journal.pone.0082294.t001
-Butyloxycarbonylation of Amines in Water, Organic Letters, vol.8, issue.15, pp.3259-3262, 2006. ,
DOI : 10.1021/ol0611191
Synthesis of a tri-tritiated heterobifunctional reagent, a potential tool in photoaffinity labeling technology, Journal of Labelled Compounds and Radiopharmaceuticals, vol.22, issue.2, pp.149-155, 1991. ,
DOI : 10.1021/bi00289a012
Oxidation of thiols with methyltriphenylphosphonium dichromate (MTPPD) in dichloromethane at room temperature, Journal of Sulfur Chemistry, vol.96, issue.5, pp.441-444, 2006. ,
DOI : 10.3184/0308234041209059
2-Oxazolidones from Glycidyl Ether Reactions with Acid Amides, Bulletin of the Chemical Society of Japan, vol.39, issue.11, pp.2490-2494, 1966. ,
DOI : 10.1246/bcsj.39.2490
Anticonvulsant Activity of Some 4-Aminophenylacetamides, Journal of Pharmaceutical Sciences, vol.76, issue.1, pp.18-20, 1987. ,
DOI : 10.1002/jps.2600760106
Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents, Journal of Medicinal Chemistry, vol.34, issue.2, pp.752-757, 1991. ,
DOI : 10.1021/jm00106a041
Synthetic Communications, pp.377-382, 2004. ,